APA

Giles B. M., Bissel S. J., Dealmeida D. R., Wiley C. A. & Ross T. M. (20120627). Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines. : Clinical and vaccine immunology : CVI.

Chicago

Giles Brendan M, Bissel Stephanie J, Dealmeida Dilhari R, Wiley Clayton A and Ross Ted M. 20120627. Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines. : Clinical and vaccine immunology : CVI.

Harvard

Giles B. M., Bissel S. J., Dealmeida D. R., Wiley C. A. and Ross T. M. (20120627). Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines. : Clinical and vaccine immunology : CVI.

MLA

Giles Brendan M, Bissel Stephanie J, Dealmeida Dilhari R, Wiley Clayton A and Ross Ted M. Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines. : Clinical and vaccine immunology : CVI. 20120627.